COVID-19疫苗接种后水痘-带状疱疹病毒再激活:3例病例报告
本文报告3例患者在接种第一剂不同COVID-19疫苗后3-13天出现水痘-带状疱疹病毒(VZV)再激活的典型皮损,均无免疫抑制治疗史,数周内恢复且后续剂次接种无复发。作者提示全科医生应认识这一可能的疫苗反应并做好社区告知与安抚。
要点
- 接种第一剂COVID-19疫苗后3-13天可出现VZV再激活,3例均无免疫抑制治疗史。
- 3例患者在数周内恢复,后续疫苗剂次接种后症状未复发。
- 全科医生应认识该事件,并向社区做好告知与安抚。
核心结论
- 接种第一剂COVID-19疫苗后存在VZV再激活的可能性。
- 全科医生应认识这一事件,并在社区告知与安抚中发挥重要作用。
研究设计与样本
- 病例系列,描述3例接种第一剂3种不同COVID-19疫苗后出现VZV再激活的患者。
主要发现
- 3例患者在COVID-19疫苗接种后3-13天出现VZV再激活的典型皮损。
- 3例患者均无免疫抑制治疗史。
- 3例患者在数周内恢复,后续疫苗剂次接种后症状未复发。
临床怎么用
- 全科医生接诊接种COVID-19疫苗后出现典型皮损者应考虑VZV再激活的可能。
- 全科医生应向社区告知该可能疫苗反应并进行安抚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The advent of vaccination against COVID-19 brought great expectations for the control of the pandemic. As novel vaccines, much of the associated side effects were unknown. Currently, an increasing number of reports from side effects of COVID-19 vaccines have been published, namely on cutaneous reactions. These are of utmost importance to increase our knowledge about possible undesirable effects and its prevention. METHODS: We describe a series of 3 cases who presented with varicella zoster virus (VZV) reactivation following the first dose of 3 different COVID-19 vaccines. RESULTS: Three patients sought their Family Doctor after developing typical lesions of VZV reactivation, following a period of 3-13 days after COVID-19 vaccination. None was under immunosuppressive therapy. The 3 patients recovered in a few weeks and the subsequent doses of the vaccines were administered, without recurrence of the symptoms. CONCLUSIONS: These cases highlight the possibility of VZV reactivation after the first dose of COVID-19 vaccines. Family Doctors should be aware of this event and play an important role informing and reassuring local communities for this possible vaccine reaction.
引用
- Saraiva AL, Vieira AR, Marinho MC, et al. Varicella zoster virus reactivation following COVID-19 vaccination: a report of 3 cases. Fam Pract. 2022. PMID: 35244157. doi:10.1093/fampra/cmac014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。